272 related articles for article (PubMed ID: 31492621)
1. Successful treatment by adding thalidomide to meglumine antimoniate in a case of refractory anthroponotic mucocutaneous leishmaniasis.
Goyonlo VM; Vahabi-Amlashi S; Taghavi F
Int J Parasitol Drugs Drug Resist; 2019 Dec; 11():177-179. PubMed ID: 31492621
[TBL] [Abstract][Full Text] [Related]
2. Simultaneous occurrence of cutaneous and mucocutaneous leishmaniasis caused by different genotypes of Leishmania (Viannia) braziliensis.
Hoyos CL; Quipildor M; Bracamonte E; Lauthier JJ; Cajal P; Uncos A; Korenaga M; Hashiguchi Y; Barroso PA; Marco JD
J Dermatol; 2019 Sep; 46(9):e320-e322. PubMed ID: 30938461
[No Abstract] [Full Text] [Related]
3. Refractory mucocutaneous leishmaniasis resolved with combination treatment based on intravenous pentamidine, oral azole, aerosolized liposomal amphotericin B, and intralesional meglumine antimoniate.
Basile G; Cristofaro G; Locatello LG; Vellere I; Piccica M; Bresci S; Maggiore G; Gallo O; Novelli A; Di Muccio T; Gramiccia M; Gradoni L; Gaiera G; Bartoloni A; Zammarchi L
Int J Infect Dis; 2020 Aug; 97():204-207. PubMed ID: 32505874
[TBL] [Abstract][Full Text] [Related]
4. Associated-risk determinants for anthroponotic cutaneous leishmaniasis treated with meglumine antimoniate: A cohort study in Iran.
Aflatoonian MR; Sharifi I; Aflatoonian B; Bamorovat M; Heshmatkhah A; Babaei Z; Ghasemi Nejad Almani P; Mohammadi MA; Salarkia E; Aghaei Afshar A; Sharifi H; Sharifi F; Khosravi A; Khatami M; Arefinia N; Fekri A; Farajzadeh S; Khamesipour A; Mohebali M; Gouya MM; Shirzadi MR; Varma RS
PLoS Negl Trop Dis; 2019 Jun; 13(6):e0007423. PubMed ID: 31188834
[TBL] [Abstract][Full Text] [Related]
5. Intralesional glucantime in Leishmania braziliensis braziliensis infections.
Barrios LA; Costa JM; Netto EM; Vexenat CO; Cuba CC; Marsden PD
Trans R Soc Trop Med Hyg; 1986; 80(1):173-4. PubMed ID: 3726989
[No Abstract] [Full Text] [Related]
6. Comparison of
Özbilgin A; Çavuş İ; Kaya T; Yıldırım A; Harman M
Turkiye Parazitol Derg; 2020 Mar; 44(1):12-16. PubMed ID: 32212583
[TBL] [Abstract][Full Text] [Related]
7. Involvement of tryparedoxin peroxidase (TryP) and trypanothione reductase (TryR) in antimony unresponsive of Leishmania tropica clinical isolates of Iran.
Nateghi-Rostami M; Tasbihi M; Darzi F
Acta Trop; 2022 Jun; 230():106392. PubMed ID: 35276060
[TBL] [Abstract][Full Text] [Related]
8. Treatment of Bolivian Leishmania braziliensis Cutaneous and Mucosal Leishmaniasis.
Soto J; Gutiérrez P; Soto P; Paz D; Cayhuara E; Molina C; Sánchez M; Berman J
Am J Trop Med Hyg; 2022 Jan; 106(4):1182-1190. PubMed ID: 35385826
[TBL] [Abstract][Full Text] [Related]
9. [Treatment of the mucosal form of leishmaniasis without response to glucantime, with liposomal amphotericin B].
Sampaio RN; Marsden PD
Rev Soc Bras Med Trop; 1997; 30(2):125-8. PubMed ID: 9148335
[TBL] [Abstract][Full Text] [Related]
10. Successful response to liposomal amphotericin B in mucosal leishmaniasis in glans resistant to intralesional pentavalent.
Aguayo-Carreras P; Cuenca-Barrales C; Perez-López I; Ruiz-Villaverde R; Tercedor-Sanchez J
Int J Dermatol; 2019 Jul; 58(7):e137-e138. PubMed ID: 30883705
[No Abstract] [Full Text] [Related]
11. Host's immune response in unresponsive and responsive patients with anthroponotic cutaneous leishmaniasis treated by meglumine antimoniate: A case-control study of Th1 and Th2 pathways.
Bamorovat M; Sharifi I; Aflatoonian MR; Sadeghi B; Shafiian A; Oliaee RT; Keyhani A; Afshar AA; Khosravi A; Mostafavi M; Parizi MH; Khatami M; Arefinia N
Int Immunopharmacol; 2019 Apr; 69():321-327. PubMed ID: 30771740
[TBL] [Abstract][Full Text] [Related]
12. Clinical characteristics of human Leishmania braziliensis braziliensis infections.
Llanos Cuentas EA; Cuba CC; Barreto AC; Marsden PD
Trans R Soc Trop Med Hyg; 1984; 78(6):845-6. PubMed ID: 6533860
[No Abstract] [Full Text] [Related]
13. American tegumentary leishmaniasis in Brazil: a critical review of the current therapeutic approach with systemic meglumine antimoniate and short-term possibilities for an alternative treatment.
Carvalho SH; Frézard F; Pereira NP; Moura AS; Ramos LMQC; Carvalho GB; Rocha MOC
Trop Med Int Health; 2019 Apr; 24(4):380-391. PubMed ID: 30681239
[TBL] [Abstract][Full Text] [Related]
14. Good response to pentamidine isethionate in a case of Mucosal Leishmaniasis caused by Leishmania (Viannia) braziliensis that was difficult to treat: Case Report.
Ferreira Terceiro BR; Torraca TSS; Braga FPB; Martins ACDC; Brahim LR; Saheki MN; Miranda LFC; Schubach AO; Valete-Rosalino CM
Rev Soc Bras Med Trop; 2019 Jan; 52():e20180236. PubMed ID: 30652793
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness of meglumine antimoniate against L. tropica in a recently emerged focus of cutaneous leishmaniasis in Birjand, eastern Islamic Republic of Iran.
Karamian M; Bojd MS; Salehabadi A; Hemmati M; Barati DA
East Mediterr Health J; 2015 Jun; 21(4):280-6. PubMed ID: 26077523
[TBL] [Abstract][Full Text] [Related]
16. Mucosal leishmaniasis unresponsive to glucantime therapy successfully treated with AmBisome.
Nonata R; Sampaio R; Marsden PD
Trans R Soc Trop Med Hyg; 1997; 91(1):77. PubMed ID: 9093636
[No Abstract] [Full Text] [Related]
17. Global distribution of treatment resistance gene markers for leishmaniasis.
Salari S; Bamorovat M; Sharifi I; Almani PGN
J Clin Lab Anal; 2022 Aug; 36(8):e24599. PubMed ID: 35808933
[TBL] [Abstract][Full Text] [Related]
18. The effect of oral miltefosine in treatment of antimoniate resistant anthroponotic cutaneous leishmaniasis: An uncontrolled clinical trial.
Tayyebi M; Darchini-Maragheh E; Layegh P; Kiafar B; Goyonlo VM
PLoS Negl Trop Dis; 2021 Mar; 15(3):e0009241. PubMed ID: 33739976
[TBL] [Abstract][Full Text] [Related]
19. Unresponsiveness to Glucantime treatment in Iranian cutaneous leishmaniasis due to drug-resistant Leishmania tropica parasites.
Hadighi R; Mohebali M; Boucher P; Hajjaran H; Khamesipour A; Ouellette M
PLoS Med; 2006 May; 3(5):e162. PubMed ID: 16605301
[TBL] [Abstract][Full Text] [Related]
20. Cutaneous leishmaniasis in Switzerland: first experience with species-specific treatment.
Mosimann V; Neumayr A; Hatz C; Blum JA
Infection; 2013 Dec; 41(6):1177-82. PubMed ID: 23835701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
